AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Palantir and OneMedNet Partner to Enhance Healthcare Data Platform with AI Technology.
ByAinvest
Monday, Oct 6, 2025 4:26 pm ET1min read
OneMedNet has partnered with Palantir Technologies to enhance its healthcare data platform using Palantir's AI tools. The platform will deliver anonymized data to life sciences and research organizations, speeding up medical studies and product development. OneMedNet CEO Aaron Green said Palantir's system "revolutionizes our ability to deliver high-quality, compliant data at remarkable speed." Despite recent revenue declines, OneMedNet shares have risen over 100% in six months.
OneMedNet Corporation has announced a strategic partnership with Palantir Technologies to enhance its healthcare data platform using Palantir's AI tools. This collaboration aims to deliver anonymized data to life sciences and research organizations, significantly speeding up medical studies and product development. The integration of Palantir's Artificial Intelligence Platform will provide the infrastructure for OneMedNet's near real-time AI-powered provider network, enabling the company to empower life sciences, medical device, and research organizations with regulatory-grade clinical data and advanced analytics [1].OneMedNet CEO Aaron Green stated, "Palantir's system revolutionizes our ability to deliver high-quality, compliant data at remarkable speed." This partnership comes at a critical juncture as access to healthcare data remains a key barrier to unlocking the $868 billion market opportunity in AI-driven healthcare by 2030. By leveraging Palantir's software, OneMedNet can combine its expansive provider network with Palantir's advanced analytics, unlocking scalable recurring revenue opportunities on a secure, regulatory-grade platform [1].
Under the multi-year agreement, Palantir's AI platform will integrate with OneMedNet's network, which provides access to more than 5 billion administrative claims and 131 million clinical exams across 1,750+ provider sites, spanning oncology, cardiology, and rare diseases. This integration will enable faster data discovery, accurate data delivery, and increased productivity, among other benefits [1].
Despite recent revenue declines, OneMedNet shares have risen over 100% in six months, reflecting investor confidence in the company's ability to leverage cutting-edge technology to drive growth and innovation in the healthcare sector. The partnership with Palantir Technologies is expected to further bolster OneMedNet's position in the market, as it continues to expand its market reach and independently broaden its global footprint [1].
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet